Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

Overview of attention for article published in Trials, May 2021

Altmetric Badge

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 169 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 14 X posts from 10 X users, with an upper bound of 23,064 followers.

RT @IDDOnews: #ScienceReadForSunday: Read paper from Lakshmi Manoharan @laksh_manoharan @ERGO_Horby ‘Chemoprophylaxis trial designs in epid…

Reply Repost Favourite

RT @IDDOnews: #ScienceReadForSunday: Read paper from Lakshmi Manoharan @laksh_manoharan @ERGO_Horby ‘Chemoprophylaxis trial designs in epid…

Reply Repost Favourite

#ScienceReadForSunday: Read paper from Lakshmi Manoharan @laksh_manoharan @ERGO_Horby ‘Chemoprophylaxis trial designs in epidemics: insights from a systematic review of #COVID19 study registrations’ https://t.co/uXXdk3ys5p

Reply Repost Favourite

RT @TropMedOxford: Research Highlight from Lakshmi Manoharan @laksh_manoharan @ERGO_Horby Chemoprophylaxis trial designs in epidemics: insi…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.